Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users

Drug and Alcohol Dependence

Volumn 43, Issue 1-2, 1996, Pages 71-77

  Brown, Lawrence S ^a,b   Sawyer, Robert C ^a   Li, Ronald ^c,d   Cobb, Malik N ^a   Colborn, David C ^c   Narang, P K ^c  

^a Addict Res Treatment Corporation   (United States)

^b HARLEM HOSPITAL CENTER   (United States)

^c PFIZER INC   (United States)

^d and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Human immunodeficiency virus; Injecting drug users; Interactions; Methadone; Narcotic withdrawal; Pharmacokinetics

Indexed keywords

METHADONE; NARCOTIC AGENT; RIFABUTIN; ZIDOVUDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG HALF LIFE; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; KIDNEY CLEARANCE; MALE; PRIORITY JOURNAL; SYMPTOM; WITHDRAWAL SYNDROME;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030566850     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)84352-9     Document Type: Article

References (26)

1. Brown, L.S., Burkett, W. and Primm, B.J. (1988) Drug treatment and HIV seropositivity. NY State J. Med. 88, 156.
2. Brown, L.S., Chu, A., Nemoto, et al. (1989) Human immunodeficiency virus infection in a cohort of New York City intravenous drug users: demographic, behavioral and clinical features. NY State J. Med. 89, 506-510.
3. Brown, L.S. and Primm, B.J. (1988) Intravenous drug abuse and AIDS in minorities. AIDS Publ. Policy 3, 5-15.
4. Centers for Disease Control and Prevention (CDC) (1991) The HIV/AIDS Epidemic: The First Ten Years. MMWR 40, 359-369.
5. Chin, D.P., et al. (1994) Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with HIV infection. J. Infect. Dis. 169, 289-295.
6. Des Jarlais, D.C., Marmor, M., Cohen, H., et al. (1984) Antibodies to a retrovirus ecologically associated with acquired immunodeficiency syndrome (AIDS) in populations with increased incidences of the syndrome. MMWR 33, 377-379.
7. Dole, V.P. and Kreek, M.J. (1973) Methadone plasma levels: Sustained by a reservoir of drug in tissues. Proc. Nat. Acad. Sci. 70, 10.
8. Inturissi, C.E. and Verebely, K. (1972) A gas-liquid chromatography method for the quantitative determination of methadone in human plasma and tissue. J. Chromatogr. 65, 361-369.
9. Kreek, M.J. (1973) Plasma and urine levels of methadone. Comparison following four medication forms used in chronic maintenance treatment. NY State J. Med. 73, 2773-2777.
10. Kreek, M.J., Dodes, L., Kane, S., et al. (1972) Long-term methadone maintenance therapy: effects on liver function. Ann. Int. Med. 77, 598-602.
11. Kreek, M.J., Garfield, J.W., Gutjarh, C.L. and Guisti, L.M. (1976a) Rifampin induced methadone withdrawal. N. Engl. J. Med. 294, 1104-1106.
12. Kreek, M.J., Gutjarh, C.L., et al. (1976b) Drug interactions with methadone. Ann. NY Acad. Sci. 281, 350-371.
13. Kreek, M.J., Rothschild, M.A., Bowen, D.V., et al. (1976c) Hepatic extraction and metabolism of methadone and other narcotics by perfused rabbit liver. Gastroenterology 67, 805.
14. Mandell, G.L. and Petri, W.A. (1996) Drugs used in the chemotherapy of tuberculosis. Mycobacterium avium complex disease and leprosy. In: Goodman and Gilman's Pharmacological Basis of Therapeutics, 9th edn. (Hardman, J.G., Limbird, L.E., Molinoff, P.B. and Ruddon, R.W., eds.). McGraw-Hill, New York.
15. Metzger, D.S., et al. (1993) HIV seroconversion among in and out of treatment intravenous drug users: an 18-month prospective follow-up. AIDS 9, 1049-1056.
16. Narang, P.K., et al. (1993) Assessing dosing implications of enzyme inducing potential: Rifabutin (RIF) vs. Rifampin (RFM). 33rd ICAAC, New Orleans, LA, Abstract 598.
17. Nightingale, S.D., Cameron, D.W., Gordin, F.M., et al. (1993) Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. New Eng. J. Med. 329, 828-833.
18. Novick, D.M., Joseph, H., Croxson, T.S., et al. (1990) Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone-maintenance patients. Arch. Int. Med. 150, 97-99.
19. Novick, D., Kreek, M.J., Des Jarlais, D.C., et al. (1986) Antibody to LAV, the putative agent of AIDS, in parenteral drug abusers and methadone-maintained patients: Abstract of clinical research findings: Therapeutic, historical and ethical aspects. In: Problems of Drug Dependence, 1985. Proc. 47th Ann. Sci. Meet. Comm. on Problems of Drug Dependence (Harris, L.S., ed.), pp. 318-320. NIDA Research Monograph 1986, DHHS publication No. (ADM) 86-1448.
20. Schwartz, E.L., et al. (1992) Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection. J. AIDS 5, 616-626.
21. Selwyn, P.A., Hartel D., Wasserman, W.A. and Drucker, E. (1989) Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am. J. Public Health 79, 1358-1362.
22. Siegal, S, and Castellano, N.J. (1988) Non-Parametric Statistics for the Behavioral Sciences, 2nd edn., McGraw-Hill, New York.
23. Sullivan, H.R. and Bluke, D.A. (1972) Quantitative determination of methadone concentrations in human blood, plasma and urine by gas chromatography. Res. Comm. Chem. Pathol. Pharmacol. 3, 467-478.
24. Sullivan, H.R, and Due, S.L. (1973) Urinary metabolites of dl-methadone in maintenance subjects. J. Med. Chem. 16, 909-913.
25. Tamassia, V., Santarato, D., et al. (1986) Disposition and fate of 14C rifabutin administered orally to healthy volunteers. Internal Adria Laboratories Report, No. 609.
26. Traxler, P., Vischer, W.A. and Zak, O. (1988) New Rifamycins. Drug. Future 13, 845-856.